The Broker Innovation Lab celebrates brokers and other benefits stakeholders who have embraced the changing marketplace to position themselves and their business for future success
Alan Goforth is a freelance writer in suburban Kansas City. In addition to freelancing for several publications, he has written a dozen books about sports and other topics.
Health care fraud remained a leading source of settlements and judgments with more than $5.7 billion of the total settlements and judgments last year were related to matters involving the industry.
This case is part of a broader effort by the attorney general's office to examine electronic health record vendors' compliance with Texas laws governing parental access to minors' health records.
The objective of the Agentic AI-Enabled Cardiovascular Care Transformation (ADVOCATE) is to develop technology that could schedule appointments, adjust medications and support diet and exercise.
Notably, female GLP-1 users experienced a 47% reduction in hospitalizations for major cardiovascular events; approximately 50% lower incidence of ovarian cancer; and a 14% lower incidence of breast cancer compared to female non-users.
"If health insurance premiums rise faster than wages and general inflation, small employers are likely to face intensified financial strain, which could accelerate the erosion of health plan sponsorship among firms with fewer than 100 workers," said Paul Fronstin, Ph.D., director of health benefits research for the Employee Benefit Research Institute.
“At a time when health care costs continue to soar, we are taking a stand against insulin price manipulation and fraud,” said Missouri Attorney General Catherine Hanaway.
The ERISA Litigation Reform Act, introduced by Rep. Randy Fine, R-Fla., is intended to curb meritless class-action lawsuits by clarifying the pleading standard applicable to ERISA-prohibited transactions claims.
The nation’s three primary insulin manufacturers (Eli Lilly, Novo Nordisk and Sanofi) and three largest PBMs (CVS Caremark, Express Script and OptumRx) are named in the lawsuit.